Lipid nanoparticles (LNPs) have revolutionized the field of drug delivery through their
applications in siRNA delivery to the liver (Onpattro) and their use in the Pfizer-BioNTech …

Protein‐based drugs have shown unique advantages to treat various diseases in recent
years. However, most protein therapeutics in clinical use are limited to extracellular targets …

Proteins and peptides have played a pivotal role in revolutionizing disease treatment over
the last century. Despite their commercial success, protein therapeutics can be eliminated or …

Internalizing therapeutic molecules or genes into cells and safely delivering them to the
target tissue where they can perform the intended tasks is one of the key characteristics of …

In recent studies, lipid nanoparticles have attained attention as drug delivery systems owing
to their preeminent potential in achieving the desired bioavailability of Biopharmaceutics …

The recent development of RNA‐based therapeutics in delivering nucleic acids for gene
editing and regulating protein translation has led to the effective treatment of various …

Since most current studies have focused on exploring how phagocyte internalization of drug-
loaded nanovesicles by macrophages would affect the function and therapeutic effects of …

As nano medications have developed in the recent four decades, nano-delivery systems
have been applied in treating various diseases and are especially common in cancer …

Protein therapeutics are of widespread interest due to their successful performance in the
current pharmaceutical and medical fields, even though their broad applications have been …

Over the last three decades, proteins and peptides have attracted great interest as drugs of
choice for combating a broad spectrum of diseases, including diabetes mellitus, cancer, and …